263
Views
12
CrossRef citations to date
0
Altmetric
Articles/Brief Reports

Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study

, , , , &
Pages 59-66 | Accepted 08 Feb 2021, Published online: 29 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pamela Wurmann, Claudio Karsulovic, Francisca Sabugo, Claudia Hernandez, Pedro Zamorano Soto & Macarena Mac-Namara. (2022) Cranial versus Extracranial Involvement in Giant Cell Arteritis: 15 Years Retrospective Cohort Analysis. Open Access Rheumatology: Research and Reviews 14, pages 97-101.
Read now
Alwin Sebastian, Alessandro Tomelleri & Bhaskar Dasgupta. (2021) Current and innovative therapeutic strategies for the treatment of giant cell arteritis. Expert Opinion on Orphan Drugs 9:5, pages 161-173.
Read now

Articles from other publishers (10)

Philipp Bosch, Georgina Espigol-Frigolé, Maria C Cid, Susan P Mollan & Wolfgang A Schmidt. (2024) Cranial involvement in giant cell arteritis. The Lancet Rheumatology 6:6, pages e384-e396.
Crossref
Kornelis S M van der Geest, Maria Sandovici, Thorsten A Bley, James R Stone, Riemer H J A Slart & Elisabeth Brouwer. (2024) Large vessel giant cell arteritis. The Lancet Rheumatology 6:6, pages e397-e408.
Crossref
Russell Machin, Tom Sulkin, Giles Maskell & Mark Hughes. (2024) Diagnosis of large vessel vasculitis in the community: a specific benefit from a non-specific symptom pathway. Rheumatology.
Crossref
H. K. Skaug, B. T. Fevang, J. Assmus, A. P. Diamantopoulos, G. Myklebust & L. K. Brekke. (2023) Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013–2020. Frontiers in Medicine 10.
Crossref
Lien Moreel, Walter CoudyzerLennert Boeckxstaens, Albrecht Betrains, Geert Molenberghs, Steven Vanderschueren, Eveline Claus, Koen Van Laere & Daniel Blockmans. (2023) Association Between Vascular 18 F-Fluorodeoxyglucose Uptake at Diagnosis and Change in Aortic Dimensions in Giant Cell Arteritis . Annals of Internal Medicine 176:10, pages 1321-1329.
Crossref
Suellen Anne Lyne, Carlee Ruediger, Susan Lester, Gursimran Kaur, Lisa Stamp, Ernst Michael Shanahan & Catherine Louise Hill. (2023) Phénotype et complications cliniques de l’artérite à cellules géantes avec atteinte des gros vaisseaux : revue systématique et méta-analyse. Revue du Rhumatisme 90:5, pages 552-564.
Crossref
Philipp Bosch, Milena Bond, Christian Dejaco, Cristina Ponte, Sarah Louise Mackie, Louise Falzon, Wolfgang A Schmidt & Sofia Ramiro. (2023) Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open 9:3, pages e003379.
Crossref
Alessandro Tomelleri, Corrado Campochiaro, Nicola Farina, Letizia Mariotti, Elena Baldissera, Peter C Grayson, Marco Matucci-Cerinic & Lorenzo Dagna. (2023) Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study. Seminars in Arthritis and Rheumatism 59, pages 152174.
Crossref
Nicola Farina, Alessandro Tomelleri, Corrado Campochiaro & Lorenzo Dagna. (2023) Giant cell arteritis: Update on clinical manifestations, diagnosis, and management. European Journal of Internal Medicine 107, pages 17-26.
Crossref
Milena Bond, Alessandro Tomelleri, Frank Buttgereit, Eric L. Matteson & Christian Dejaco. (2022) Looking ahead: giant-cell arteritis in 10 years time. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210963.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.